These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 9436248

  • 1. Prostatic conformal brachytherapy: 125I/103Pd postoperative dosimetric analysis.
    Merrick GS, Butler WM, Dorsey AT, Walbert HL.
    Radiat Oncol Investig; 1997; 5(6):305-13. PubMed ID: 9436248
    [Abstract] [Full Text] [Related]

  • 2. Comparison of seed loading approaches in prostate brachytherapy.
    Butler WM, Merrick GS, Lief JH, Dorsey AT.
    Med Phys; 2000 Feb; 27(2):381-92. PubMed ID: 10718143
    [Abstract] [Full Text] [Related]

  • 3. Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy.
    Merrick GS, Butler WM, Dorsey AT, Walbert HL.
    Radiat Oncol Investig; 1998 Feb; 6(4):182-90. PubMed ID: 9727878
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rectal dosimetric analysis following prostate brachytherapy.
    Merrick GS, Butler WM, Dorsey AT, Lief JH, Walbert HL, Blatt HJ.
    Int J Radiat Oncol Biol Phys; 1999 Mar 15; 43(5):1021-7. PubMed ID: 10192350
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
    Prestidge BR, Bice WS, Kiefer EJ, Prete JJ.
    Int J Radiat Oncol Biol Phys; 1998 Mar 15; 40(5):1111-5. PubMed ID: 9539566
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
    Dicker AP, Lin CC, Leeper DB, Waterman FM.
    Semin Urol Oncol; 2000 May 15; 18(2):152-9. PubMed ID: 10875458
    [Abstract] [Full Text] [Related]

  • 14. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
    Grills IS, Martinez AA, Hollander M, Huang R, Goldman K, Chen PY, Gustafson GS.
    J Urol; 2004 Mar 15; 171(3):1098-104. PubMed ID: 14767279
    [Abstract] [Full Text] [Related]

  • 15. Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
    Butler WM, Merrick GS, Dorsey AT, Lief JH.
    Med Phys; 2000 May 15; 27(5):1067-75. PubMed ID: 10841411
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Permanent implant brachytherapy for early, organ-confined prostate cancer].
    Agoston P, Major T, Fröhlich G, Baricza K, Szabó Z, Lövey J, Varjas G, Kásler M, Fodor J, Polgár C.
    Magy Onkol; 2011 Sep 15; 55(3):170-7. PubMed ID: 21918742
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.